Manish Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Manish Mishra has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Surabhi Bajpai
Banaras Hindu University
6 shared publicationsHemant Kumar
5 shared publications- Kamlakar Tripathi
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi
3 shared publications Raju Panta
3 shared publicationsVinod Kumar
Department of Biochemistry, Faculty of Science, Banaras Hindu University, Varanasi 221 005, India
3 shared publicationsKamlakar Tripathi
2 shared publications
Latest Publications
- 4 November 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1383
Novel benzothiazole-amino acid functionalized terbinafine ionic conjugates: synthesis, DFT, docking, and antifungal evaluation
- 4 November 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1383
Novel benzothiazole-amino acid functionalized terbinafine ionic conjugates: synthesis, DFT, docking, and antifungal evaluation
- Open Access
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Medical Technology
- Vol. 5, 1219073
Editorial: Relevant technology adaptation for bio medical application and sustainability
Editorial: Relevant technology adaptation for bio medical application and sustainability
- 5 July 2023
- Published by Frontiers Media SA in Frontiers in Medical Technology
- Vol. 5, 1219073
Open AccessEditorial: Relevant technology adaptation for bio medical application and sustainability
Editorial: Relevant technology adaptation for bio medical application and sustainability
- Open Access
- 21 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11105
Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive disease that affects millions of adults every year. Major risk factors include diabetes, hypertension, and obesity, which affect millions of adults worldwide. CKD is characterized by cellular injury followed by permanent loss of functional nephrons. As injured cells die and nephrons become sclerotic, remaining healthy nephrons attempt to compensate by undergoing various structural, molecular, and functional changes. While these changes are designed to maintain appropriate renal function, they may lead to additional cellular injury and progression of disease. As CKD progresses and filtration decreases, the ability to eliminate metabolic wastes and environmental toxicants declines. The inability to eliminate environmental toxicants such as arsenic, cadmium, and mercury may contribute to cellular injury and enhance the progression of CKD. The present review describes major molecular alterations that contribute to the pathogenesis of CKD and the effects of arsenic, cadmium, and mercury on the progression of CKD.
- 21 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11105
Open AccessMolecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive disease that affects millions of adults every year. Major risk factors include diabetes, hypertension, and obesity, which affect millions of adults worldwide. CKD is characterized by cellular injury followed by permanent loss of functional nephrons. As injured cells die and nephrons become sclerotic, remaining healthy nephrons attempt to compensate by undergoing various structural, molecular, and functional changes. While these changes are designed to maintain appropriate renal function, they may lead to additional cellular injury and progression of disease. As CKD progresses and filtration decreases, the ability to eliminate metabolic wastes and environmental toxicants declines. The inability to eliminate environmental toxicants such as arsenic, cadmium, and mercury may contribute to cellular injury and enhance the progression of CKD. The present review describes major molecular alterations that contribute to the pathogenesis of CKD and the effects of arsenic, cadmium, and mercury on the progression of CKD.
- Open Access
- 16 April 2018
- Published by Juniper Publishers in Journal of Endocrinology and Thyroid Research
- Vol. 3 (3)
Association of Diabetes Mellitus and Thyroid Disorders: An Adipocytokines Prospective
Journal of Endocrinology and Thyroid Research (JETR) works mainly on the publication of the papers related to the endocrinology which is meant by study of the all glands present in human body like Thyroid, Pituitary, Endocrine, etc
- 16 April 2018
- Published by Juniper Publishers in Journal of Endocrinology and Thyroid Research
- Vol. 3 (3)
Open AccessAssociation of Diabetes Mellitus and Thyroid Disorders: An Adipocytokines Prospective
Journal of Endocrinology and Thyroid Research (JETR) works mainly on the publication of the papers related to the endocrinology which is meant by study of the all glands present in human body like Thyroid, Pituitary, Endocrine, etc
- 1 March 2018
- Published by Marwah Infotech in Asian Pacific Journal of Health Sciences
- Vol. 5 (1) , 1-8
Effectiveness of carbohydrate diet restriction in type 2 diabetes mellitus on insulin and incretin-based therapies
- 1 March 2018
- Published by Marwah Infotech in Asian Pacific Journal of Health Sciences
- Vol. 5 (1) , 1-8
Effectiveness of carbohydrate diet restriction in type 2 diabetes mellitus on insulin and incretin-based therapies
- 30 September 2017
- Published by Marwah Infotech in Asian Pacific Journal of Health Sciences
- Vol. 4 (3) , 253-262
Association of Diabetes Mellitus and Thyroid Disorders: A Metabolic Prospective
- 30 September 2017
- Published by Marwah Infotech in Asian Pacific Journal of Health Sciences
- Vol. 4 (3) , 253-262
Association of Diabetes Mellitus and Thyroid Disorders: A Metabolic Prospective
- 1 October 2016
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 6 (10) , 827-831
Influence of coffee and its components on breast cancer: A review
- 1 October 2016
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 6 (10) , 827-831
Influence of coffee and its components on breast cancer: A review
- 1 August 2013
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 3 (4) , 331-336
Therapeutic rationale for low dose doxepin in insomnia patients
- 1 August 2013
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 3 (4) , 331-336
Therapeutic rationale for low dose doxepin in insomnia patients
- Open Access
- 1 January 2013
- Published by Science Publications in OnLine Journal of Biological Sciences
- Vol. 13 (1) , 13-17
THE PROBABLE MEDICINAL USAGE OF CASSIA TORA: AN OVERVIEW
Cassia tora (C. tora) is a small shrub budding as weed in Asian and African countries. It is a known edible leafy vegetable taken up by Asians. From time immemorial, different parts of C. tora have found application in Indian and Chinese medicine. Its varying useful medicinal effects are well documented in many publications. In this review we have compiled the traditional medicinal usage of C. tora which have been confirmed by scientific studies
- 1 January 2013
- Published by Science Publications in OnLine Journal of Biological Sciences
- Vol. 13 (1) , 13-17
Open AccessTHE PROBABLE MEDICINAL USAGE OF CASSIA TORA: AN OVERVIEW
Cassia tora (C. tora) is a small shrub budding as weed in Asian and African countries. It is a known edible leafy vegetable taken up by Asians. From time immemorial, different parts of C. tora have found application in Indian and Chinese medicine. Its varying useful medicinal effects are well documented in many publications. In this review we have compiled the traditional medicinal usage of C. tora which have been confirmed by scientific studies
- 5 May 2012
- Published by Springer Nature in Parasitology Research
- Vol. 111 (4) , 1851-1855
Detection and diagnostic applicability of human urinary kininogen in kala-azar patients
The present study was aimed to detect urinary proteins excreted in kala-azar patients. Urinary proteins were isolated by ammonium sulfate precipitation and purified by Amicon ultra using 3 kDa cutoff membrane device. The proteins were resolved on 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis and blots were developed with the patients sera. The excretion of urinary proteins was differential in kala-azar patients. A total eight proteins of molecular weights 25, 28, 46, 54, 57, 60, 72, and 95 kDa were detected in the urine of visceral leishmaniasis (VL) patients. On blot, the 57 kDa protein was found to be host origin and characterized as human kininogen. All other proteins were leishmanial origin. Out of 50 urine samples analyzed, the kininogen was detected in 45 urine samples. Following treatment, this protein was not detectable in the urine samples of any patient. The appearance of kininogen in urine of VL patients offers a novel possibility for the development of diagnostic tool and a test of cure.
- 5 May 2012
- Published by Springer Nature in Parasitology Research
- Vol. 111 (4) , 1851-1855
Detection and diagnostic applicability of human urinary kininogen in kala-azar patients
The present study was aimed to detect urinary proteins excreted in kala-azar patients. Urinary proteins were isolated by ammonium sulfate precipitation and purified by Amicon ultra using 3 kDa cutoff membrane device. The proteins were resolved on 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis and blots were developed with the patients sera. The excretion of urinary proteins was differential in kala-azar patients. A total eight proteins of molecular weights 25, 28, 46, 54, 57, 60, 72, and 95 kDa were detected in the urine of visceral leishmaniasis (VL) patients. On blot, the 57 kDa protein was found to be host origin and characterized as human kininogen. All other proteins were leishmanial origin. Out of 50 urine samples analyzed, the kininogen was detected in 45 urine samples. Following treatment, this protein was not detectable in the urine samples of any patient. The appearance of kininogen in urine of VL patients offers a novel possibility for the development of diagnostic tool and a test of cure.